Cannabis

Home Office written question – answered on 15th November 2016.

Alert me about debates like this

Photo of Roger Godsiff Roger Godsiff Labour, Birmingham, Hall Green

To ask the Secretary of State for the Home Department, if she will respond to the recommendations of the report by the All-Party Parliamentary Group for Drug Policy Reforms Accessing Medicinal Cannabis: Meeting Patients' Needs, published in September 2016.

Photo of Sarah Newton Sarah Newton The Parliamentary Under-Secretary of State for the Home Department

The Prime Minister responded to the All-Party Parliamentary Group for Drug Policy Reform’s report ‘Accessing Medicinal Cannabis: Meeting Patients' Needs’ on the 27 October.

Cannabis is controlled as a Class B drug under the Misuse of Drugs Act 1971 and, in its raw form, currently has no recognised medicinal benefits in the UK. It is therefore listed as a Schedule 1 drug under the Misuse of Drugs Regulations 2001.

It is important that all medicines containing controlled drugs are thoroughly trialled to ensure they meet rigorous standards so that doctors and patients are sure of their efficacy and safety. To do otherwise for cannabis would amount to a circumvention of the clearly established and necessary regime for approving medicines in the UK.

Does this answer the above question?

Yes2 people think so

No139 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.